Unveiling new protein biomarkers and therapeutic targets for acne through integrated analysis of human plasma proteomics and genomics

Our comprehensive analysis of proteomic and genetic data from a European adult cohort provides compelling causal evidence that several proteins are promising targets for novel acne treatments.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2024-10-18
DOI
https://doi.org/10.3389/fimmu.2024.1452801
Citations
4
Primary Topic
Acne and Rosacea Treatments and Effects
Type
article
Field-Weighted Citation Impact
2.14
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Unveiling new protein biomarkers and therapeutic targets for acne through integrated analysis of human plasma proteomics and genomics

Rui Mao, Sui Deng, Yifeng He
4 citations
Frontiers in Immunology
Acne and Rosacea Treatments and Effects
2.14
article

Unveiling new protein biomarkers and therapeutic targets for acne through integrated analysis of human plasma proteomics and genomics

Rui Mao, Sui Deng, Yifeng He
article en
4 citations

Abstract

Our comprehensive analysis of proteomic and genetic data from a European adult cohort provides compelling causal evidence that several proteins are promising targets for novel acne treatments.

Frontiers in ImmunologyVol. 15
Central South University (CN), The First People's Hospital of Changde (CN), Xiangya Hospital Central South University (CN)
Good health and well-being
Openalex Percentile: Top 12%
Acne and Rosacea Treatments and Effects
2.14
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.